Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Julian
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   34    
Direct Shares   1,028,565    

Indirect Shares

   246,186,665      
Direct Value   $74,276,455    

Indirect Value

   $16,601,740,960      
Total Shares   247,215,230      
Total Value   $16,676,017,415      


Incyte Corp $32,797,033 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,178,868 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,231,765 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $286,709 Incyte Corp $32,797,033 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,178,868 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,231,765 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $286,709
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    46   
    7    

     Stock price went up :
    23   
    7    
     Stock price went down :
    23   
    0    
   
     Gain/Loss Ratio :
   0.0   
   7.0   
     Percentage Gain/Loss :
   11.8%
 80.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA 10% Owner 2003-09-26 0 2011-11-02 144,082    Premium*  
            Innoviva Inc INVA Director 2005-12-13 0 2004-10-04 33,839    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2004-10-13 0 2011-06-30 4,045,398    Premium*  
            Incyte Corp INCY 2024-05-07 559,963 2024-05-07 33,496,391    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2019-08-29 0 2019-08-29 9,262,659    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 2009-01-23 0 2009-01-23 2,258    Premium*  
            Viropharma Inc VPHM 10% Owner 0 2011-12-14 9,840,469    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2009-10-19 5,264,782    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2012-01-27 0    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 2011-08-22 0 2012-02-10 557,211    Premium*  
            XOMA Corporation XOMA Former 10% owner 0 2015-07-22 90,538    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 3,540,015    Premium*  
            Neurogene NGNE Director 2020-07-07 4,520 2020-07-07 3,501,691    Premium*  
            Acadia Pharmaceuticals Inc ACAD 2024-05-29 205,752 2024-05-29 39,349,751    Premium*  
            Invitae Corp NVTA 10% Owner 2018-03-28 0 2018-03-28 7,553,553    Premium*  
            Aceragen, Inc ACGN 10% Owner 2019-07-01 43,858 2019-07-01 4,290,995    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM Former 10% owner 2017-10-05 0 2017-10-05 1,878,242    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2017-11-08 274 2017-11-08 35,999    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2018-01-17 0 2018-01-19 58,131    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2021-06-16 20,838 2021-06-16 11,703,086    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2021-05-14 46,557 2021-05-14 43,309,073    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2020-05-14 131,963 2020-05-14 7,940,623    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director, 10% Owner 2019-06-06 14,840 2019-06-06 2,700,597    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2018-10-09 0 2021-09-30 13,526,726    Premium*  
            Atreca Inc BCEL 10% Owner 2019-06-24 0 2019-06-24 3,223,030    Premium*  
            Igm Biosciences, Inc. IGMS Director, 10% Owner 2019-09-20 0 2021-01-27 2,895,306    Premium*  
            Prelude Therapeutics Inc PRLD Director, 10% Owner 0 2021-01-27 9,252,951    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 0 2021-01-01 4,286,038    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 0 2021-02-17 7,003,766    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE Director 0 2021-02-23 3,410,106    Premium*  
            Tscan Therapeutics, Inc. TCRX Director 2021-07-20 0 2021-07-20 1,320,302    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 0 2021-12-14 4,704,419    Premium*  
            Bicycle Therapeutics Ltd BCYC 0 2024-04-18 6,449,320    Premium*  
            Immunocore Holdings Adr IMCR 0 2024-05-28 1,515,318    Premium*  
* Premium Members only  

Records found :    498         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 18 of 20
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2008-04-04 4 B $13.28 $4,158,884 I/I 313,169 2,245,340 1.5 -
XOMA XOMA Corporation Director   –       •       •   2014-12-16 4 S $4.27 $1,363,271 I/I (319,200) 443,096 0 -
BLCM Bellicum Pharmaceuticals,... 10% Owner   –       –       •   2018-01-18 4 S $8.12 $2,635,768 I/I (324,774) 62,267 0 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2008-05-07 4 A $0.00 $0 I/I 331,452 2,604,774 0 -
INCY Incyte Corp Director   –       •      –    2007-11-12 4 B $8.00 $2,851,531 I/I 346,207 2,278,707 2.1 -
INCY Incyte Corp Director   –       •       •   2021-12-15 4 B $67.90 $25,052,340 I/I 350,332 29,687,509 2.25 %
RDEA Ardea Biosciences Inc Director   –       •       •   2011-01-20 4 B $26.00 $9,245,210 I/I 355,585 4,036,097 2.25 -
NGNE Neurogene 10% Owner   –       –       •   2016-03-16 4 B $7.70 $2,893,570 I/I 361,755 6,928,119 1.5 -
GHDX Genomic Health Inc Director   –       •      –    2006-12-01 4 B $18.95 $7,705,696 I/I 380,870 1,093,914 2.1 -
SGEN Seagen Inc Director   –       •       •   2020-05-06 4 S $164.06 $64,379,473 I/I (390,072) 45,502,996 0 %
XOMA XOMA Corporation Director   –       •       •   2014-12-30 4 S $3.65 $1,430,239 I/I (391,900) 392,617 0 -
XOMA XOMA Corporation Director   –       •       •   2014-12-09 4 S $4.62 $1,811,062 I/I (392,353) 465,335 0 -
NGNE Neurogene 10% Owner   –       –       •   2017-01-09 4 B $15.13 $6,836,813 I/I 398,062 9,764,459 1.5 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2019-06-06 4 D $0.00 $0 I/I (421,756) 3,315,146 0 -
NGNE Neurogene Director   –       •      –    2020-07-07 4 B $15.25 $6,466,000 I/I 424,000 3,501,691 2.1 -
VPHM Viropharma Inc 10% Owner   –       –       •   2010-04-30 4 B $12.76 $5,503,790 I/I 431,154 9,080,664 1.5 -
INCY Incyte Corp Director   –       •       •   2019-06-06 4 A $0.00 $0 D/D 440,282 281,190 0 -
XOMA XOMA Corporation Director   –       •       •   2014-12-15 4 S $4.45 $2,050,652 I/I (460,800) 449,970 0 -
RDEA Ardea Biosciences Inc Director   –       •       •   2010-04-06 4 B $20.00 $9,731,380 I/I 486,569 3,680,512 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2018-11-30 4 D $0.00 $0 I/I (489,977) 0 0 -
XOMA XOMA Corporation Director   –       •       •   2014-12-02 4 S $5.36 $2,679,550 I/I (500,000) 513,815 0 -
SGEN Seagen Inc Director   –       •       •   2020-05-08 4 S $158.50 $79,250,000 I/I (500,000) 44,891,148 0 %
VPHM Viropharma Inc 10% Owner   –       –       •   2011-10-03 4 B $17.62 $9,134,858 I/I 516,203 9,357,416 1.5 -
XOMA XOMA Corporation Director   –       •       •   2014-12-03 4 S $4.84 $2,748,837 I/I (567,918) 501,850 0 -
BGNE Beigene Ltd Director   –       •       •   2019-06-06 4 D $0.00 $0 I/I (582,200) 18,591 0 -
  498  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18  19   20      
  Page 18 of 20  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us